Vaxelis Dosing After Birth Hepatitis B Vaccine
Yes, an infant who receives the hepatitis B vaccine at birth can and should receive 3 doses of Vaxelis at 2,4, and 6 months of age—this is the CDC-recommended standard schedule. 1, 2
Standard Vaccination Schedule
The recommended approach is straightforward:
- Birth: Monovalent hepatitis B vaccine (Vaxelis is NOT licensed for birth dose) 1, 2
- 2 months: First dose of Vaxelis 1, 2
- 4 months: Second dose of Vaxelis 1, 2
- 6 months: Third dose of Vaxelis 1, 2
This schedule results in a total of 4 doses of hepatitis B vaccine (1 monovalent + 3 in Vaxelis), which is safe, well-tolerated, and does not increase adverse reactions. 3
Critical Timing Requirements
The third dose of Vaxelis must be given at or after 24 weeks of age to ensure adequate hepatitis B immune response. 1, 2 Key timing parameters include:
- Minimum age for first Vaxelis dose: 6 weeks 1, 2
- Minimum interval between doses: 4 weeks 1, 2
- Minimum age for third dose: 24 weeks (approximately 6 months) 1, 2
Common Pitfall to Avoid
If the third Vaxelis dose is inadvertently given before 24 weeks of age, you must administer an additional monovalent hepatitis B vaccine dose at ≥24 weeks to complete the series. 1, 2 This is because adequate hepatitis B immune response requires the final dose at or after 24 weeks of age. 1
Maternal Hepatitis B Status Considerations
The schedule works regardless of maternal status:
- HBsAg-negative mothers: Standard schedule as above (birth HepB + Vaxelis at 2,4,6 months) 1, 2
- HBsAg-positive or unknown status mothers: Same Vaxelis schedule can be used, but these infants require monovalent hepatitis B vaccine PLUS hepatitis B immune globulin (HBIG) within 12 hours of birth 1, 2
Important Limitations
Vaxelis should NOT be used for booster doses. 1, 2 After completing the 3-dose primary series:
- A separate DTaP vaccine is needed for the fourth dose at 15-18 months 2
- A separate Hib conjugate vaccine is needed for the booster at 12-15 months 2
- A separate IPV vaccine is needed for the fourth dose at 4-6 years 2
Special Population Note
For American Indian/Alaska Native infants, the CDC does not have a preferential recommendation for Vaxelis due to limited data on antibody response after the first dose in this population. 1, 2 These infants historically benefit from vaccines containing PRP-OMP (which provides protection after the first dose), and Vaxelis does not contain this formulation. 1